PHASE 1 CLINICAL TRIAL UNITS FOR THERAPEUTICS AGAINST INFECTIOUS DISEASES: ADMINISTRATIVE SUPPORT
Abstract
The Phase I Clinical Trial Units provide a vehicle for the investigation of new therapeutic and immunomodulatory agents for the treatment of infectious disease.
Key facts
- NIH application ID
- 10383310
- Project number
- 272201500006I-0-759302100001-1
- Recipient
- DUKE UNIVERSITY
- Principal Investigator
- ROB CAUDLE
- Activity code
- N01
- Funding institute
- NIH
- Fiscal year
- 2021
- Award amount
- $109,972
- Award type
- —
- Project period
- 2014-12-15 → 2021-12-14